General Information of Drug Transporter (DT)
DT ID	DTD0031 Transporter Info
Gene Name	SLCO2B1
Protein Name	Organic anion transporting polypeptide 2B1
Gene ID	11309
UniProt ID	O94956
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs12422149
Site of GPD	chr11:75172532 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A / G>T
Minor Allele Frequency	A=0.2099/1051 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Montelukast	Drug Info	Healthy Individuals	Irrelevant to the drug clearance in healthy individuals (compare with allele G)		[ 1]
Genotype AG	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Montelukast	Drug Info	Asthma	Correlated with the decreased drug response in patients (compare with genotype GG)		[ 2]
Genetic Polymorphism	rs2306168
Site of GPD	chr11:75196537 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	C>T
Minor Allele Frequency	T=0.1803/903 (Global)
Allele T	Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Fexofenadine	Drug Info	Healthy Individuals	Correlated with the decreased area under the plasma concentration-time curve (AUC) in healthy individuals (compare with genotype CC)		[ 3]
References
1	Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans. J Clin Pharmacol. 2013 Nov;53(11):1186-93.
2	Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics. 2009 Feb;19(2):129-38.
3	The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet Genomics. 2011 Feb;21(2):84-93.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.